1 Table of Contents
|1 Table of Contents 3
|1.1 List of Tables 5
|1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Hip Reconstruction Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Hip Reconstruction Market, United States 9
3.1 Hip Reconstruction Market, United States, Revenue ($m), 2015-2025 9
3.1.1 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.2 Hip Reconstruction Market, United States, Volume (Units), 2015-2025 15
3.2.1 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025 17
3.2.2 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025 19
3.3 Hip Reconstruction Market, United States, Average Price ($) , 2015-2025 21
3.4 Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019 23
3.5 Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2019 24
4 Overview of Key Companies in United States, Hip Reconstruction Market 26
4.1 Zimmer Biomet Holdings Inc 26
4.1.1 Company Overview 26
4.2 Stryker Corp 26
4.2.1 Company Overview 26
4.3 DePuy Synthes Inc 26
4.3.1 Company Overview 26
4.4 Smith & Nephew Plc 27
4.4.1 Company Overview 27
4.5 MicroPort Scientific Corp 27
4.5.1 Company Overview 27
4.6 Exactech Inc 27
4.6.1 Company Overview 27
4.7 Medacta Group SA 27
4.7.1 Company Overview 27
5 Hip Reconstruction Market Pipeline Products 28
6 Financial Deals Landscape 29
6.1 Debt Offerings 29
6.1.1 Stryker Prices USD600 Million in Public Offering of
0.600% Senior Notes Due 2023 29
6.1.2 Stryker Raises USD650 Million in Public Offering of
1.15% Notes Due 2025 30
6.1.3 Stryker Raises USD1 Billion in Public Offering of
1.95% Notes Due 2030 32
6.1.4 Stryker Raises USD650 Million in Public Offering of
2.9% Notes Due 2050 34
6.1.5 Zimmer Biomet Prices Public Offering of
3.55% Notes Due 2030 for USD900 Million 36
6.1.6 Zimmer Biomet Prices Public Offering of
3.05% Notes Due 2026 for USD600 Million 38
6.2 Equity Offerings 40
6.2.1 SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities 40
6.2.2 SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares 41
6.2.3 SINTX Technologies Prices Private Placement of Shares for USD3 Million 43
6.2.4 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 44
6.2.5 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 46
6.2.6 Sintx Technologies to Raise USD8.8 million in Rights Offering 47
7 Recent Developments 49
7.1 Corporate Communications 49
7.1.1 Mar 05, 2020: Ovid Therapeutics announces presentations on OV935/TAK935 (soticlestat) at the American Academy of Neurology 2020 Annual Meeting 49
7.1.2 Mar 02, 2020: Stryker announces new Investor Relations leader 49
7.1.3 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 50
7.1.4 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 50
7.1.5 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 51
7.1.6 Jan 25, 2020: Siemens Healthineers India launches ACUSON Redwood Ultrasound System at IRIA 2020 51
7.1.7 Jan 22, 2020: Amiri Hospital in Kuwait goes lives with Agfa HealthCare’s Enterprise Imaging for Radiology 52
7.1.8 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer 54
7.1.9 Jan 06, 2020: Exactech announces leadership transition 54
7.2 Financial Announcements 55
7.2.1 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results 55
7.2.2 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 55
7.3 Government and Public Interest 56
7.3.1 Jun 30, 2020: HSS study identifies RA patients with worse outcomes after hip or knee replacement 56
7.4 Other Significant Developments 57
7.4.1 Sep 16, 2020: Willamette Surgery Center now offering highly advanced robotic-arm assisted joint replacement procedures with Stryker's mako system 57
7.4.2 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education 58
7.4.3 May 28, 2020: Conformis announces settlement of patent dispute 58
7.5 Product News 58
7.5.1 Jun 08, 2020: No difference in outcomes between anterior and posterior surgical approaches for outpatient total hip replacement 58
7.6 Strategy And Business Planning 59
7.6.1 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis 59
7.6.2 Jan 23, 2020: Brainlab acquires San Diego-based VisionTree Software 60
7.6.3 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience 60
8 Appendix 62
8.1 Research Methodology 63
8.1.1 Coverage 63
8.1.2 Secondary Research 63
8.1.3 Primary Research 64
8.1.4 Market Modeling and Forecasting 65
8.1.5 Company Share Analysis 66
8.1.6 Distribution Share Analysis 66
8.1.7 Benchmarking 67
8.2 GlobalData Consulting 67
8.3 Contact Us 68
8.4 Disclaimer 68